The Food and Drug Administration (FDA) has approved Zepbound to help treat obstructive sleep apnea (OSA ... for certain people with obesity. Medicare Part D prescription drug plans may cover ...

Zepbound (tirzepatide) is a weekly injectable weight-loss medication. It can be purchased online or in person with a valid ...

Zepbound (tirzepatide) is a prescription drug that’s used for weight loss and obstructive sleep apnea in certain adults. Zepbound comes as a liquid solution inside prefilled injection pens.

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Zepbound isn’t just about looking good for your high school reunion. The FDA has officially given this medication their stamp of approval for both weight loss and treating sleep apnea in people ...

There is a need to identify patients with obstructive sleep apnea after a weight-loss drug was approved for treatment of the ...

Due to current legislation regarding weight loss drugs, Medicare Part D or Part C plans with drug coverage may only cover Zepbound for treating obstructive sleep apnea (OSA). However, the Centers ...